Advertisement
UK markets closed
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • CRUDE OIL

    83.11
    +1.76 (+2.16%)
     
  • GOLD FUTURES

    2,254.80
    +42.10 (+1.90%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • Bitcoin GBP

    56,108.75
    +1,503.27 (+2.75%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,379.46
    -20.06 (-0.12%)
     
  • UK FTSE All Share

    4,338.05
    +12.12 (+0.28%)
     

Top Ranked Growth Stocks to Buy for January 31st

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 31st:

Focus Financial Partners (FOCS): This company which provides wealth management services to primarily high net worth individuals and families carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.

Focus Financial Partners Inc. Price and Consensus

Focus Financial Partners Inc. Price and Consensus
Focus Financial Partners Inc. Price and Consensus

Focus Financial Partners Inc. price-consensus-chart | Focus Financial Partners Inc. Quote

Focus Financial has a PEG ratio of 0.46, compared with 1.22 for the industry. The company possesses a Growth Score of A.

ADVERTISEMENT

Focus Financial Partners Inc. PEG Ratio (TTM)

Focus Financial Partners Inc. PEG Ratio (TTM)
Focus Financial Partners Inc. PEG Ratio (TTM)

Focus Financial Partners Inc. peg-ratio-ttm | Focus Financial Partners Inc. Quote

Alexion Pharmaceuticals, Inc. (ALXN): This company that develops and commercializes various therapeutic products, carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.

Alexion Pharmaceuticals, Inc. Price and Consensus

Alexion Pharmaceuticals, Inc. Price and Consensus
Alexion Pharmaceuticals, Inc. Price and Consensus

Alexion Pharmaceuticals, Inc. price-consensus-chart | Alexion Pharmaceuticals, Inc. Quote

Alexion has a PEG ratio of 0.60, compared with 2.43 for the industry. The company possesses a Growth Score of B.

Alexion Pharmaceuticals, Inc. PEG Ratio (TTM)

Alexion Pharmaceuticals, Inc. PEG Ratio (TTM)
Alexion Pharmaceuticals, Inc. PEG Ratio (TTM)

Alexion Pharmaceuticals, Inc. peg-ratio-ttm | Alexion Pharmaceuticals, Inc. Quote

Delta Air Lines, Inc. (DAL): This provider of scheduled air transportation for passengers and cargo, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

Delta Air Lines, Inc. Price and Consensus

Delta Air Lines, Inc. Price and Consensus
Delta Air Lines, Inc. Price and Consensus

Delta Air Lines, Inc. price-consensus-chart | Delta Air Lines, Inc. Quote

Delta Air Lines has a PEG ratio of 0.56, compared with 1.26 for the industry. The company possesses a Growth Score of A.

Delta Air Lines, Inc. PEG Ratio (TTM)

Delta Air Lines, Inc. PEG Ratio (TTM)
Delta Air Lines, Inc. PEG Ratio (TTM)

Delta Air Lines, Inc. peg-ratio-ttm | Delta Air Lines, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.    

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Focus Financial Partners Inc. (FOCS) : Free Stock Analysis Report
 
Delta Air Lines, Inc. (DAL) : Free Stock Analysis Report
 
Alexion Pharmaceuticals, Inc. (ALXN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research